Cancer Clinical Decision Tools Global Market Report 2023

Feb 2023| TBR1167D| TBRC (Publisher)

Report Highlights

Including: 1) By Type: Risk Assessment Tool(RAT); Qcancer
2) By End-User: Hospital; Clinics
Covering: McKesson Corporation; Medical Information Technology Inc.; Philips Healthcare; Siemens Healthineers; Elsevier B.V.

Cancer Clinical Decision Tools Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cancer clinical decision tools market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Description:
Where is the largest and fastest growing market for cancer clinical decision tools ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cancer clinical decision tools market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

Report Synopsis

Report Metrics Details
Base year considered 2022
Forecast period considered 2022-2032
Units considered $ Billion
Segments covered By Type, By End-User
Industry covered Pharmaceuticals
Regions covered Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Countries covered Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA
Companies studied
  • Macmillan
  • National Decision Support Company
  • McKesson Corporation
  • Medical Information Technology Inc.
  • Philips Healthcare
  • Siemens Healthineers
  • Elsevier B.V.

Scope

Markets Covered:

  • By Type: Risk Assessment Tool(RAT); Qcancer
  • By End-User: Hospital; Clinics

Companies Mentioned: McKesson Corporation; Medical Information Technology Inc.; Philips Healthcare; Siemens Healthineers; Elsevier B.V.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

  • Table 1 : Global Historic Market Growth, 2017-2022, $ Billion
  • Table 2 : Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Table 3 : Global Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 4 : Global Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 5 : Global Cancer Clinical Decision Tools Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 6 : Global Cancer Clinical Decision Tools Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 7 : Asia-Pacific, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 8 : Asia-Pacific, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 9 : China, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 10 : China, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 11 : India, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 12 : India, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 13 : Japan, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 14 : Japan, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 15 : Australia, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 16 : Australia, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 17 : Indonesia, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 18 : Indonesia, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 19 : South Korea, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 20 : South Korea, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 21 : Western Europe, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 22 : Western Europe, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 23 : UK, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 24 : UK, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 25 : Germany, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 26 : Germany, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 27 : France, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 28 : France, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 29 : Eastern Europe, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 30 : Eastern Europe, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 31 : Russia, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 32 : Russia, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 33 : North America, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 34 : North America, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 35 : USA, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 36 : USA, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 37 : South America, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 38 : South America, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 39 : Brazil, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 40 : Brazil, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 41 : Middle East, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 42 : Middle East, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 43 : Africa, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 44 : Africa, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 45 : McKesson Corporation Financial Performance
  • Table 46 : Medical Information Technology Inc. Financial Performance
  • Table 47 : Philips Healthcare Financial Performance
  • Table 48 : Elsevier B.V. Financial Performance
  • Table 49 : Siemens Healthineers Financial Performance
  • Figure 1 : Global Historic Market Growth, 2017-2022, $ Billion
  • Figure 2 : Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Figure 3 : Global Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 4 : Global Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 5 : Global Cancer Clinical Decision Tools Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 6 : Global Cancer Clinical Decision Tools Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 7 : Asia-Pacific, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 8 : Asia-Pacific, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 9 : China, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 10 : China, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 11 : India, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 12 : India, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 13 : Japan, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 14 : Japan, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 15 : Australia, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 16 : Australia, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 17 : Indonesia, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 18 : Indonesia, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 19 : South Korea, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 20 : South Korea, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 21 : Western Europe, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 22 : Western Europe, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 23 : UK, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 24 : UK, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 25 : Germany, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 26 : Germany, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 27 : France, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 28 : France, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 29 : Eastern Europe, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 30 : Eastern Europe, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 31 : Russia, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 32 : Russia, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 33 : North America, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 34 : North America, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 35 : USA, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 36 : USA, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 37 : South America, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 38 : South America, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 39 : Brazil, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 40 : Brazil, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 41 : Middle East, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 42 : Middle East, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 43 : Africa, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 44 : Africa, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 45 : McKesson Corporation Financial Performance
  • Figure 46 : Medical Information Technology Inc. Financial Performance
  • Figure 47 : Philips Healthcare Financial Performance
  • Figure 48 : Elsevier B.V. Financial Performance
  • Figure 49 : Siemens Healthineers Financial Performance

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Similar Reports from TBRC (Publisher)

Cancer Clinical Decision Tools Global Market Report 2022

  • Date - Mar 2022
  • Code - TBR1167C

Including: 1) By Type: Risk Assessment Tool(RAT); Qcancer
2) By End-User: Hospital; Clinics
Covering: McKesson Corporation; Medical Information Technology inc.; Philips Healthcare; Siemens Healthineers; Elsevier B.V.

Cancer Clinical Decision Tools Global Market Report 2022 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global cancer clinical decision ...

Cancer Clinical Decision Tools Global Market Report 2021: COVID-19 Growth And Change To 2030

  • Date - Sep 2021
  • Code - TBR1167B

Including: 1) By Type: Risk Assessment Tool(RAT); Qcancer
2) By End-User: Hospital; Clinics
Covering: McKesson Corporation; Medical Information Technology Inc.; Philips Healthcare; Elsevier B.V.; Siemens Healthineers

Cancer Clinical Decision Tools Global Market Report 2021: COVID-19 Growth And Change to 2030 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to ...

Cancer Clinical Decision Tools Global Market Report 2020-30: COVID-19 Growth and Change

  • Date - Dec 2020
  • Code - TBR1167A

Including: 1) By Type: Risk Assessment Tool(RAT); Qcancer

2) By End-User: Hospital; Clinics

Covering: McKesson Corporation; Medical Information Technology Inc.; Philips Healthcare; Elsevier B.V.; Siemens Healthineers

Cancer Clinical Decision Tools Global Market Report 2020-30: Covid 19 Growth And Change from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the ...

The Business Research Company
Price: $5000

Become a Member

Already a member? Login here.

Have a Question? Ask Us.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
Custom Research

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS